Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).
Clinical trial NCT06125808 · COMPLETED
Trial details
- NCT number
- NCT06125808
- Sponsor
- Arctic Bioscience
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-25
- Primary completion
- 2024-10-07
- Enrollment
- 521
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.